Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies
Autor:
Ramos-Rincón, José-Manuel
; Pinargote-Celorio, Héctor
; de Mendoza, Carmen
; Ramos-Belinchón, Clara
; Barreiro, Pablo
; Gómez-Gallego, Felix
; Corral, Octavio Jorge
; Soriano, Vicente
Fecha:
2022Palabra clave:
Revista / editorial:
Journal of Viral HepatitisCitación:
Ramos‐Rincon, J. M., Pinargote‐Celorio, H., de Mendoza, C., Ramos‐Belinchón, C., Barreiro, P., Gómez‐Gallego, F., ... & Soriano, V. (2022). Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies. Journal of viral hepatitis, 29(9), 777-784.Tipo de Ítem:
Articulo Revista IndexadaDirección web:
https://onlinelibrary.wiley.com/doi/10.1111/jvh.13708
Resumen:
Chronic hepatitis C virus (HCV) infection is major cause of decompensated cirrhosis and liver cancer. The advent of curative new antiviral therapies since year 2015 has dramatically improved the prognosis of HCV patients. The real-life clinical benefits at country level of these therapies have not yet been assessed. This is a retrospective study of all hospitalizations in Spain including HCV as diagnosis using the Spanish National Registry of Hospital Discharges. Information was retrieved from 1997 to 2019. From 81,482,509 nationwide hospital admissions recorded during the study period, 1,057,582 (1.29%) included HCV as diagnosis. The median age of HCV hospitalized patients was 54 years old. Males accounted for 63.2% of cases. Most HCV admissions recorded chronic hepatitis C whereas acute hepatitis C was reported in less than 3%. In-hospital death occurred in 6.4% of HCV admissions. Coinfection with HIV or hepatitis B virus was seen in 14.8% and 6.4%, respectively. Patients hospitalized with HIV-HCV coinfection represented 14.8% of cases and were on average 17 years younger than HCV-monoinfected individuals. The rate of HCV hospitalizations significantly increased until 2005, and then stabilized for one decade. A significant reduction was noticed since 2015. However, whereas the proportion of HCV-associated hepatic decompensation events declined since then, liver cancer diagnoses increased. In conclusion, hospital admissions of HCV individuals significantly declined in Spain since 2015 following a wide prescription of new oral direct-acting antivirals. This reduction was primarily driven by a fall of hepatic decompensation events whereas HCV-related liver cancer continues rising.
Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
40 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
51 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Trends in hospitalizations and deaths in HIV-infected patients in Spain over two decades
Ramos-Rincón, José-Manuel; Menchi-Elanzi, Maroune; Pinargote-Celorio, Héctor; Mayoral, Asunción; González-Alcaide, Gregorio; de Mendoza, Carmen; Barreiro, Pablo; Gómez-Gallego, Felix ; Corral, Octavio Jorge ; Soriano, Vicente (AIDS, 02/2022)Background: The prognosis of HIV infection dramatically improved after the introduction of triple antiretroviral therapy 25 years ago. Herein, we report the impact of further improvements in HIV management since then, ... -
Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain
Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; de Mendoza, Carmen; Ramos-Belinchón, Clara; Barreiro, Pablo; Treviño, Ana; Corral, Octavio Jorge; Soriano, Vicente (Hepatology International, 2022)Background: Chronic viral hepatitis B, C, and D are the main causes of decompensated cirrhosis and liver cancer worldwide. Newborn HBV vaccination was implemented more than 2 decades ago in most EU countries. Furthermore, ... -
Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain
Ramos-Rincón, José-Manuel; Pinargote-Celorio, Héctor; de Mendoza, Carmen; Ramos-Belinchón, Clara; Barreiro, Pablo; Treviño, Ana; Corral, Octavio Jorge; Soriano, Vicente (Alimentary Pharmacology and Therapeutics, 2023)Background: Chronic hepatitis B virus (HBV) infection is a major cause of decompensated cirrhosis and liver cancer worldwide. Newborn HBV vaccination was implemented in Spain two decades ago, and potent oral antivirals ...